| Titre |
Buruli ulcer: A review of In Vitro tests to screen natural products for activity against Mycobacterium ulcerans |
| Auteurs |
YEMOA Loconon Y. Achille [1],
GBENOU Joachim [2],
AFFOLABI DISSOU [3],
MANSOUROU Moudachirou [4],
BIGOT KOFFI ANDRÉ [5],
ANAGONOU-YEHOUENOU SEVERIN [6],
|
| Journal: |
Planta Med |
| Catégorie Journal: |
Internationale |
| Impact factor: |
2.15 |
| Volume Journal: |
77 |
| DOI: |
|
| Resume |
Buruli ulcer (BU), caused by Mycobacterium ulcerans,
has recently been recognized by the World
Health Organization (WHO) as an important
emerging disease. It is largely a problem of the
poor in remote rural areas and has emerged as
an important cause of human suffering. While
antimycobacterial therapy is often effective for
the earliest nodular or ulcerative lesions, for advanced
ulcerated lesions, surgery is sometimes
necessary. Antimycobacterial drugs may also prevent
relapses or disseminated infections. Efficient
alternatives different from surgery are presently
explored because this treatment deals with huge
restrictive factors such as the necessity of prolonged
hospitalization, its high cost, and the scars
after surgery. Traditional treatment remains the
first option for poor populations of remote areas
who may have problems of accessibility to synthetic
products because of their high cost. The
search for efficient natural products active on
M. ulcerans should then be encouraged because
they are part of the natural heritage of these populations;
they are affordable financially and can
be used at the earliest stage. This review provides
a number of tests that will help to evaluate the
antimycobacterial activity of natural products
against M. ulcerans, which are adapted to its slow
growing rate, and lists active extracts published
up to now in Medline. |
| Mots clés |
natural products, antimycobacterial, screening, Buruli ulcer |
| Pages |
641 - 646 |
| Fichier |
(PDF) |